Month: May 2023

WASHINGTON — The Biden administration will end most of the last remaining federal COVID-19 vaccine requirements next week when the national public health emergency for the coronavirus ends, the White House said Monday. Vaccine requirements for federal workers and federal contractors, as well as foreign air travelers to the U.S., will end May 11. The … Read more

WASHINGTON — Widespread loneliness in the U.S. poses health risks as deadly as smoking a dozen cigarettes daily, costing the health industry billions of dollars annually, the U.S. surgeon general said Tuesday in declaring the latest public health epidemic. About half of U.S. adults say they’ve experienced loneliness, Dr. Vivek Murthy said in a report … Read more

NEW YORK — Bondi, an 8-month-old toy poodle, had just returned from a walk when he began stumbling. His head wobbled and soon he could barely stand, so his owner, Colleen Briggs, rushed him to the vet. The good doctor quickly made a diagnosis: Bondi was stoned. On his walk, a sniff must have led … Read more

Have you ever felt frozen, as if you can’t seem to move forward in life? Perhaps it’s as if you can’t seem to move on from a trauma or a heartbreak—or you can’t tap into the passion or enthusiasm that once came so easily. Maybe you’re so unmotivated at work that you spend time fantasizing … Read more

Attendees say many people did not mask, socially distance or take other precautions recommended earlier in the pandemic. View original article Contributor: Lena H. Sun

The U.S. government claims Gilead Sciences has made billions of dollars by capitalizing on an anti-HIV regimen patented by the CDC, while the drugmaker argues the patents are invalid. View original article Contributor: Daniel Gilbert

An advisory on loneliness from Surgeon General Vivek H. Murthy calls for a collective effort to “mend the social fabric of our nation.” View original article Contributor: Fenit Nirappil

Attendees say many people did not mask, socially distance or take other precautions recommended earlier in the pandemic. View original article Contributor: Lena H. Sun

The U.S. government claims Gilead Sciences has made billions of dollars by capitalizing on an anti-HIV regimen patented by the CDC, while the drugmaker argues the patents are invalid. View original article Contributor: Daniel Gilbert